Prostate cancer ablation registry study
Part of Cancer, Kidney & urinary clinical trials.
This study collects information from men with prostate cancer who are having or have had a procedure to destroy prostate tumors (ablation). It aims to track outcomes over time to improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man
- You are 22 years or older
- You have been diagnosed with prostate cancer
- You are scheduled for or have already had a procedure to destroy prostate tumors (ablation)
- Your ablation uses one of these methods: cryotherapy, high-intensity focused ultrasound, irreversible electroporation, laser, microwave, radiofrequency, or photodynamic therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a registry study that collects information from men with localized prostate cancer who receive transperineal laser ablation (a procedure done through the skin between the scrotum and anus). It may help doctors better understand outcomes and refine treatment choices over time.
This is a registry study for men with intermediate-risk prostate cancer who are getting a type of focal treatment (treating only the cancer spot, not the whole prostate). It collects data on treatments like HIFU, cryotherapy, and others to better understand their long-term results.
This trial tests a new device that uses gentle electrical pulses (PFA) to treat prostate cancer without cutting or heat. It is for men with various risk levels who haven't had other prostate cancer treatments.
This study looks at how well a targeted procedure (“focal ablation,” which destroys only the cancer area) works for certain men with prostate cancer that is limited to the prostate. It may help doctors understand which people benefit most and what outcomes to expect.
This study is a worldwide registry that collects health information from men with advanced prostate cancer. It may help researchers better understand disease patterns and outcomes, which can guide future treatments.
This study collects data on men with early, low-risk prostate cancer who choose to have a targeted ultrasound treatment called HIFU (High-Intensity Focused Ultrasound). It looks at how well this treatment works and how men recover.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.